Bluesight, the leading provider of Medication Intelligence solutions for health systems and hospital pharmacies, announced the acquisition of Sectyr, a top-tier compliance and audit management platform. This acquisition expands Bluesight’s portfolio to include robust 340B audit and compliance tools in response to growing demand from its customers..

。此次收购扩大了蓝光公司的投资组合，包括强大的340B审计和合规工具，以应对客户不断增长的需求。。

Sectyr is recognized for its industry-leading solutions designed to simplify and streamline regulatory compliance and auditing, specifically in the 340B Drug Pricing Program. With the addition of Sectyr’s tools, Bluesight continues its mission of empowering healthcare organizations to ensure medication safety, compliance, and operational efficiency..

Sectyr以其业界领先的解决方案而闻名，该解决方案旨在简化和简化法规遵从性和审计，特别是在340B药物定价计划中。随着Sectyr工具的加入，蓝光继续其赋予医疗保健组织权力的使命，以确保药物安全，合规性和运营效率。。

“We’re thrilled to welcome Sectyr to the Bluesight family,” said Kevin MacDonald, CEO at Bluesight. “We’ve heard from many of our customers that continued access to the 340B Program is a critical priority, and they invest a significant amount of time and effort in order to remain compliant and maintain access to the program.

Bluesight首席执行官凯文·麦克唐纳（KevinMacDonald）表示：“我们很高兴欢迎Sectyr加入Bluesight家族。”。“我们从许多客户那里得知，继续访问340B计划是一个关键的优先事项，他们投入了大量的时间和精力来保持法规遵从性并保持对该计划的访问。

There’s a clear need for better tools to ensure compliance and conduct audits. Sectyr’s deep expertise in this area made them a natural fit to help us expand our offerings and deliver even more value to our pharmacy customers.”.

显然需要更好的工具来确保法规遵从性和进行审计。Sectyr在这一领域的深厚专业知识使其自然适合帮助我们扩大产品范围，并为我们的药房客户提供更多价值。”。

James Lawson, Founder and CEO at Sectyr said, “As a former healthcare executive, I know first-hand that ensuring health systems stay compliant with HRSA regulations to maintain 340B eligibility is a top priority for hospitals nationwide. With this understanding, I founded Sectyr to support pharmacy operations teams with innovative solutions to their compliance problems.

Sectyr创始人兼首席执行官詹姆斯·劳森（JamesLawson）表示：“作为一名前医疗保健高管，我亲身体会到，确保医疗系统符合HRSA法规，以保持340B资格，是全国医院的首要任务。基于这种理解，我成立了Sectyr，以支持药房运营团队，为其合规问题提供创新解决方案。

When seeking partners to accelerate Sectyr’s mission, Bluesight stood out as a leader for over a decade across compliance, operations, and finance. We’re excited to partner with a company that shares our vision and passion for pharmacy compliance.”.

在寻找合作伙伴以加速Sectyr的使命时，蓝光公司在合规、运营和财务方面已成为十多年来的领导者。我们很高兴能与一家分享我们对药房合规性的愿景和热情的公司合作。”。

Bluesight’s acquisition of Sectyr underscores its commitment to offering best-in-class solutions that simplify medication management and compliance for pharmacies. By integrating Sectyr’s technology, Bluesight customers now have access to a comprehensive suite of tools to manage their 340B program with confidence, improving audit readiness and compliance oversight..

Bluesight收购Sectyr突显出其致力于提供一流的解决方案，简化药房的药物管理和合规性。通过整合Sectyr的技术，Bluesight客户现在可以使用一套全面的工具来自信地管理其340B计划，提高审计准备和合规监督。。

This move follows Bluesight’s continued investment in tools that streamline pharmacy workflows and enhance operational visibility, making it easier for healthcare organizations to navigate the increasingly complex regulatory environment.

在这一举措之前，蓝光公司继续投资于简化药房工作流程和增强运营可见性的工具，使医疗保健组织更容易应对日益复杂的监管环境。

About Bluesight

关于Bluesight

Bluesight simplifies medication tracking from purchase to patient administration. With a suite of Medication Intelligence solutions, Bluesight enables hospitals and health systems to worry less about inventory, compliance, and costs and focus on what matters most: patient care. More than 2,000 United States and Canadian hospitals depend on Bluesight every day to optimize pharmacy operations, prevent risk and noncompliance, and improve financial health.

Bluesight简化了从购买到患者管理的药物跟踪。凭借一套药物智能解决方案，Bluesight使医院和卫生系统能够减少对库存、合规性和成本的担忧，并专注于最重要的事情：患者护理。每天有2000多家美国和加拿大医院依靠Bluesight优化药房运营，预防风险和违规行为，并改善财务状况。

For more information, please visit Bluesight’s website..

有关更多信息，请访问Bluesight的网站。。

About Sectyr

Sectyr provides software solutions that help healthcare and other regulated businesses achieve and maintain Continuous Program Compliance with ever-changing regulatory requirements. Used by hundreds of hospitals, health centers, and pharmacies across the country, Sectyr’s cloud-based compliance platform, SectyrHub, strengthens your compliance posture with specialized yet highly configurable software solutions for HRSA 330 grant program management, HRSA 340B drug discount program management, HIPAA risk assessment, license management, accreditation management, and incident management.

Sectyr提供软件解决方案，帮助医疗保健和其他受监管的企业实现并保持持续的计划符合不断变化的监管要求。Sectyr基于云的合规平台SectyrHub被全国数百家医院、健康中心和药店使用，它为HRSA 330赠款计划管理、HRSA 340B药物折扣计划管理、HIPAA风险评估、许可证管理、认证管理和事件管理提供了专门但高度可配置的软件解决方案，从而加强了您的合规态势。

To learn more, visit sectyr.com and follow us on LinkedIn..

要了解更多信息，请访问sectyr.com并在LinkedIn上关注我们。。

Originally announced October 17th, 2024

最初于2024年10月17日宣布

TagsBluesight Health IT Acquisitions Healthcare M&A James Lawson Kevin MacDonald Sectyr

TagsBluesight Health IT收购医疗保健并购James Lawson Kevin MacDonald Sectyr

Get Fresh Healthcare & IT Stories Delivered Daily

每天提供新鲜的医疗保健和IT故事

Join thousands of your healthcare & HealthIT peers who subscribe to our daily newsletter.

加入成千上万订阅我们每日新闻稿的healthcare&HealthIT同行。

We respect your privacy and will never sell or give out your contact information

我们尊重您的隐私，绝不出售或泄露您的联系信息